South Korea expands regional medical-school quotas through 2031 to boost non-Seoul healthcare.

The South Korean Ministry of Education on Tuesday announced the regional allocation plan for medical-school quotas covering the 2027 to 2031 academic years. For the five medical schools in the Daedejeon–Chungnam region, the plan projects 72 additional seats in 2027, followed by an increase to as many as 90 additional seats per year from 2028 through 2031. The move targets regional, not Seoul-based, medical schools.

Chungnam National University College of Medicine will see its quota rise from 110 to 137 for the 2027 academic year, and then to 143 from 2028 through 2031. This represents the largest single-campus increase among the five institutions in the plan.

Keimyung University College of Medicine, based in Daegu, is set to grow from 49 to 55 seats in 2027, with a further increase to 57 seats from 2028 through 2031.

Dankook University College of Medicine in Cheonan would increase from 40 to 55 seats in 2027, and to 58 seats for 2028–2031. This marks a sizable expansion for the Cheonan campus within the five-school regional group.

SoonChunHyang University College of Medicine, serving Asan and surrounding areas, would expand from 93 to 111 seats in 2027, and to 116 seats from 2028 through 2031.

Eulji University College of Medicine would see its quota grow from 40 to 46 seats in 2027, and to 48 seats from 2028 through 2031. The five schools collectively exclude Seoul-based programs, reflecting a regional focus of the plan.

The Education Ministry said regional allocations were determined after reviewing each university’s submitted adjustment plans, educational conditions, facility-expansion plans, and on-site inspection results. The goal appears to be expanding medical training capacity outside Seoul to address regional needs in healthcare access and workforce distribution.

For international readers, the development matters beyond Korea because a stronger regional medical workforce in South Korea can influence how healthcare services are delivered nationwide, affect regional health outcomes, and shape partnerships with foreign research and medical institutions. As South Korea faces an aging population and evolving biotechnology and medical-device sectors, changes in where doctors are trained may influence future clinical talent pipelines, research collaboration opportunities, and Korea’s role in global health markets.

The move also aligns with broader policy aims to rebalance regional development and healthcare capacity, potentially affecting how international partners engage with Korea’s medical research and clinical education ecosystems. In the United States, long-term shifts in Korea’s physician supply and regional healthcare access could inform bilateral discussions on medical education exchanges, collaborative research, and cross-border health initiatives.